Under Section 503B, a compounded drug is deemed essentially a copy if it is identical or nearly identical to a commercially available approved drug, or if it contains a bulk drug substance that is a component of an approved drug, unless there is a change that produces a clinical difference for an individual patient, as determined by the prescribing practitioner
BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome, and other hereditary cancer syndromes create environments where additional risk factors deserve careful consideration
Single-peptide protocols often require higher dosages to achieve clinical efficacy, increasing the risk of adverse events
Several studies recommend splitting supplemental L-carnitine intake into two or three doses, says Rickelle Tallent, RDN, LD, owner of Tallent Nutrition & Wellness in Las Vegas, Nevada
Saving face So, what can you do about Ozempic face if youre contemplating GLP-1/GIP drugs, or are already using them